SIGLEC1 (CD169) is a sensitive biomarker for the deterioration of the clinical course in childhood systemic lupus erythematosus

BACKGROUND: To analyse the validity of membrane-bound SIGLEC1 (CD169) as a sensitive biomarker for monitoring disease activity in pediatric systemic lupus erythematosus (SLE). METHODS: 27 children and adolescents with SLE were followed for a mean of 13.5 months. During consecutive routine visits SLE...

Descripción completa

Detalles Bibliográficos
Autores principales: von Stuckrad, Sae Lim, Klotsche, Jens, Biesen, Robert, Lieber, Mareike, Thumfart, Julia, Meisel, Christian, Unterwalder, Nadine, Kallinich, Tilmann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684796/
https://www.ncbi.nlm.nih.gov/pubmed/33081587
http://dx.doi.org/10.1177/0961203320965699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684796/
https://www.ncbi.nlm.nih.gov/pubmed/33081587
http://dx.doi.org/10.1177/0961203320965699

Ejemplares similares